CDIO

Cardio Diagnostics Holdings Inc

0.3011

Top Statistics
Market Cap 12 M Forward PE -1.31 Revenue Growth 356.20 %
Current Ratio 5.69 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.7190 Enterprise / Revenue 151.00 Price To Sales Trailing12 Months 311.12
Profitability
Profit Margins 0.00 % Operating Margins -16295.55 %
Balance Sheet
Total Cash 1 M Total Cash Per Share 0.0550 Total Debt 870448
Total Debt To Equity 28.31 Current Ratio 5.69 Book Value Per Share 0.1440
All Measures
Short Ratio 70.00 % Message Board Id finmb_1671478040 Shares Short Prior Month 2 M
Return On Equity -2.93 City Chicago Uuid b9cf1495-9333-3575-a79c-036cdcf1cc6c
Previous Close 0.3110 First Trade Date Epoch Utc 1 B Book Value 0.1440
Beta 4.68 Total Debt 870448 Volume 1 M
Price To Book 2.09 Fifty Two Week Low 0.1900 Total Cash Per Share 0.0550
Total Revenue 39138 Shares Short Previous Month Date 1 B Target Median Price 2.00
Max Age 86400 Recommendation Mean 1.00 Sand P52 Week Change 0.3133
Operating Margins -16295.55 % Target Mean Price 2.00 Net Income To Common -8772890
Short Percent Of Float 0.0552 Implied Shares Outstanding 40 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 2 M Average Volume10days 2 M
Total Cash 1 M Next Fiscal Year End 1 B Revenue Per Share 0.0020
Held Percent Insiders 0.0986 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 0.3110 Target Low Price 2.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.2605 Open 0.3042
Free Cashflow -5918657 State IL Dividend Yield 0.00 %
Return On Assets -0.9795 Time Zone Short Name EST Trailing Eps -0.3000
Day Low 0.2783 Address1 311 West Superior Street Shares Outstanding 40 M
Price Hint 4 Target High Price 2.00 Website https://cardiodiagnosticsinc.com
52 Week Change -0.8525 Average Volume 3 M Forward Eps -0.2500
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 350.30 %
Is_sp_500 False Regular Market Day High 0.3042 Profit Margins 0.00 %
Debt To Equity 28.31 Fifty Two Week High 3.56 Day High 0.3042
Shares Short 1 M Regular Market Open 0.3042 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 151.00 Revenue Growth 356.20 %
Shares Percent Shares Out 0.0549 Operating Cashflow -5173726 Currency USD
Time Zone Full Name America/New_York Market Cap 12 M Is_nasdaq_100 False
Zip 60654 Quote Type EQUITY Industry Biotechnology
Long Name Cardio Diagnostics Holdings, Inc. Regular Market Day Low 0.2783 Held Percent Institutions 0.0415
Current Price 0.3011 Address2 Suite 444 Enterprise To Ebitda -0.7190
Financial Currency USD Current Ratio 5.69 Gross Margins 100.00 %
Industry Disp Biotechnology Number Of Analyst Opinions 1 Country United States
Float Shares 20 M Two Hundred Day Average 0.6665 Enterprise Value 5 M
Price To Sales Trailing12 Months 311.12 Forward PE -1.31 Regular Market Volume 1 M
Ebitda -8215199 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.

Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.